Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» obesity
obesity
Roche reports positive data from Phase I obesity treatment trial
Clinical Trials Arena
Wed, 07/17/24 - 12:18 pm
Roche
CT-996
clinical trials
obesity
Move over, oncology: Obesity, diabetes meds will take over 2030's top drug rankings, Evaluate forecasts
Fierce Pharma
Fri, 07/12/24 - 11:33 am
obesity
diabetes
oncology
Novo Nordisk
Eli Lilly
Pfizer's obesity pill news leaves analysts wanting, biotech investors cheering
Fierce Biotech
Fri, 07/12/24 - 11:14 am
Pfizer
obesity
danuglipron
Viking Therapeutics
Terns Pharmaceuticals
Vivani to start in-human trial for GLP-1 implant for treating obesity
Clinical Trials Arena
Fri, 07/12/24 - 11:08 am
Vivani Medical
clinical trials
GLP-1 implant
obesity
Weight-loss drugs could become a test case for AI
Axios
Tue, 07/9/24 - 09:24 pm
artificial intelligence
weight loss
obesity
GLP-1 agonist
GLP-1s May Cut Risk of 10 Obesity-Related Cancers in Diabetes Patients: Study
BioSpace
Mon, 07/8/24 - 11:49 am
GLP-1
Ozempic
Novo Nordisk
Eli Lilly
obesity
cancer
Boehringer Ingelheim and Gubra begin Phase I trial of drug candidate for obesity
Clinical Trials Arena
Tue, 07/2/24 - 11:19 am
Boehringer Ingelheim
Gubra
clinical trials
BI 3034701
obesity
India panel urges drug regulator to approve Lilly's obesity drug Mounjaro
Reuters
Mon, 07/1/24 - 09:52 pm
Eli Lilly
Mounjaro
India
obesity
House committee backs some Medicare cover for obesity drugs
Pharmaphorum
Fri, 06/28/24 - 11:13 am
legislation
Medicare
obesity
Wegovy
Zepbound
Zealand Pharma brings in $1B to drive development of obesity drugs
First Word Pharma
Wed, 06/26/24 - 10:04 am
Zealand Pharma
obesity
funding
Pfizer's Working on the Next Wegovy, but Can It Beat Novo Nordisk?
Motley Fool
Tue, 06/25/24 - 11:17 am
Pfizer
Novo Nordisk
obesity
Ozempic
ProFound Therapeutics
Altimmune Targets Obesity Market With Weight-Loss Drug That Preserves Lean Muscle Mass
BioSpace
Mon, 06/24/24 - 10:18 pm
Altimmune
pemvidutide
weight loss
clinical trials
obesity
Obesity drug from Zealand shows potential in early trial
BioPharma Dive
Thu, 06/20/24 - 05:57 pm
Zealand Pharma
obesity
clinical trials
petrelintide
Sanders hopes pressure will force down Ozempic price
Axios
Thu, 06/20/24 - 11:23 am
Novo Nordisk
drug pricing
Ozempic
obesity
Bernie Sanders
Could Structure Therapeutics Become the Next Novo Nordisk?
Motley Fool
Mon, 06/17/24 - 11:38 am
Structure Therapeutics
weight loss
Novo Nordisk
obesity
GS-1290
GLP-1 global obesity market to reach $111B by 2033, despite headwinds: GlobalData
BioSpace
Fri, 06/14/24 - 11:48 am
GLP-1 agonists
Novo Nordisk
Eli Lilly
obesity
weight loss
Employer coverage for weight-loss drugs rises sharply, survey finds
Reuters
Thu, 06/13/24 - 11:05 pm
insurance
weight loss
obesity
Eli Lilly
Novo Nordisk
Wegovy
Zepbound
Palatin Technologies commences Phase II study of obesity treatment
Clinical Trials Arena
Thu, 06/13/24 - 11:03 am
Palatin
clinical trials
breatelanotide
obesity
Pfizer, Flagship name first target for multibillion-dollar collaboration: obesity
Fierce Biotech
Wed, 06/12/24 - 11:16 am
Pfizer
Flagship Pioneering
ProFound Therapeutics
obesity
drug development
Syntis Bio Launches in Effort to Challenge GLP-1s in Lucrative Weight Loss Market
BioSpace
Tue, 06/11/24 - 11:27 am
Syntis Bio
obesity
weight loss
SYNT-101
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »